SpeechPathology.com Phone: 800-242-5183


eLuma Online Therapy - Love What You Do - August 2024

Laryngeal Spasms

George Charpied, M.S.,CCC-SLP

December 17, 2007

Share:

Question

I recently conducted a modified barium swallow study on a patient who complained of severe coughing episodes at the beginning of her meals that subsided as she ate. During the MBS, the patient did cough forcefully with a bite of cookie. Several other item

Answer

First, it is important to understand that '...laryngeal spasm(s)...' is symptomatic of something and may have many etiologies. An irritable upper aerodigestive system has been shown to be disruptive to a patient's life (Koufman, 96, in Ballenger and Snow, Eds., Otolaryngology (15), Chap. 30, Williams and Wilkins, Phila., pp. 535-555). Acute laryngospasm is an incapacitating event with obscure etiology (Corey, et al., 99, Orolaryngol. Clinics of No. Amer., 31(1): 189-205). The Speech-Pathologist who posed this question described the signs and symptoms most likely associated with a hypersensitivity syndrome. However, it is important to have a thoroughgoing differential diagnosis before proceeding. A differential diagnosis would include ruling out Stevens-Johnson syndrome (a mucocutaneous hypersensitivity syndrome; Roujeau, et. al., 95, New Eng. Jour Med., 333(24): 1600-1608), autoimmune disorders (Campbell, et al., 83, Am. Jour. Otolaryngol., 4: 187-216) [i.e., rheumatoid arthritis (Rh factor mediated autoimmune disorder), systemic lupus erythematosis (DNA autoantibody), cicatricial pemphigoid (idiopathic epithelial autoimmunity), relapsing polychondritis (cartilaginous autoimmunity), Sjogren's syndrome (idiopathic connective tissue autoimmunity), etc.], cervical esophageal diverticulum (Zenker's), respiratory syncytial viral bronchiolitis (Khoshoo and Edell, 99, Pediatrics, 104: 1389-1390), 'irritable larynx' syndrome (Morrison, et al., 9, Jour. Voice, 13(3):447-455), eosinophilic esophagitis (Liacouras, et al., 98, Pediatrics Suppl., 104(2): 364-365), medication sensitivities (i.e., ACE-inhibitor angioedema) and tumor masses, benign or malignant (DuBuske, et al., 96, Chap. 29, in MP Fried, Ed., The Larynx, Mosby, Boston, pp. 319-333), any physiological conditions known to manifest as hyper-reactivity (i.e., paradoxical vocal fold mobility impairment; Selner, et al., 87, Jour. Allergy Clin. Immunol., 79: 726-733), and, finally, gastroesophageal and laryngopharyngeal reflux disorder (Kozarek, 90, Gastroenterol. Clin. No. Amer., 19: 713-731; Filiaci, et al., 97, Allergol. Immunopathol., 25: 266-271).

Second, if the nature of the disorder is indeed hypersensitivity, it is necessary to collect a life-time history from the patient searching for a continuity of symptoms the patient may report (Yu and Ryu, 97, Mayo Clinic Proced., 72: 957-959). Aerodigestive hypersensitivity has been shown to exist within the entire age spectrum, from the infant to the geriatric patient. Next, one would want to probe the patient carefully to discern any patterns for the occurrence of the symptoms. Evidence one would be looking for would be specific foods allergies (i.e., sulfides, aspartamine, the preservatives BHA and BHT, benzoles, tartrazine, the flavor enhancer MSG and food colorings), environmental agents [i.e., dust mites, animal danders of both pets and vermine, and molds), and inhalants (e.g., seasonal pollens, fumes and smoke, aerosolized chemicals, both industrial and household)] (Curtis and Crain, 06, Dysphagia, 2(2): 93-96) that may cause episodes of immunologic response.

Third, if a pattern were to be discerned, either for digestive or laryngeal impairment due to hypersensitivity, testing to determine the nidus of the problem is recommended. Under the management of an Otolaryngoloist (ENT), the most basic level treatment is empirical. The ENT may decide to try coughing suppressants (e.g., Theobromine) or expectorants (e.g., Guaifenesin), improving daily water intake (i.e., hydration), and/or the use of nighttime humidifiers. At the next level the ENT may start the patient on an aggressive regime for the medical management of reflux suppression, including the use of proton pump inhibitors, such as Prilosec or Prevacid, and the establishment of reflux precautions as behavioral management, antihistamines (e.g., Benadryl, Pyribenzamine, Chlor-Tremeton, etc.),or mast cell stabilizers (e.g., Cromolyn sodium). Finally, the ENT may decide to do testing of respiratory function, including the methacholine inhalation challenge, looking for signs of asthma, and imaging studies to identify anatomical abnormalities that may exist. Lastly, the ENT may decide to test the patient for allergen sensitivities with skin or blood samples for the radioallergosorbent test (Krouse and Mabry, 03, Otoalryngol. - Head and Neck Surg., Suppl., 129(4): S33-S49).

Fourth, and lastly, treatment, like most successful speech-language-pathology (SLP) intervention, is interdisciplinary. Working with the ENT, a Pulmonologist, counselors, and other necessary professionals, the SLP can launch into a regiment to establish behavioral management methods with goals to improve breathing, swallowing, and speaking impairments (Rothe and Karrer, 98, Eur. Respir. Jour., 11: 498-500). This includes continued avoidance of inciting agents (Squillance, 92, Otolaryngol. - Head and Neck Surg., Suppl., 107(6): Part 2: 831-834), management of autoimmune conditions, if required, staying with medication regimes, and developing individualized programs of diaphragmatic breathing, easy onset voice production, and mealtime management of food intake by monitoring rate and volume during the feeding cycle (Irwin, et al., 97, Arch. Intern. Med., 157: 1981-1987). The condition of laryngospasm has been given short shrift when no obvious etiology or cause appears to exist. But to the patient this is a significant impairment that reduces their quality of their life. We are thus obligated to be as thorough as is practicable when addressing this complaint.

Mr. Charpied is the Director of the Department of Speech Pathology, in the Department of Otolaryngology - Head and Neck Surgery, with the University Rochester's School of Medicine and Strong Memorial Hospital. A clinically certified Speech Pathologist who specializes in voice and swallowing, Mr. Charpied has developed techniques and manuals on the diagnosis, treatment and management of voice and swallowing disorders. He teaches at Nazareth College, as well in the ENT resident program. His research interests include anatomy of the larynx, quantification of laryngeal function through image analysis, and the use of computers as a clinical tool. Besides publications and numerous abstracts, Mr. Charpied's introductory text for speech pathology students, Introduction to the Anatomy and Physiology of the Speech Mechanism - Elements of Human Communication, will be published spring of 2007.


George Charpied, M.S.,CCC-SLP


Related Courses

Treatment Approach Considerations for School-Aged Children with Speech Sound Disorders
Presented by Kathryn Cabbage, PhD, CCC-SLP
Video

Presenter

Kathryn Cabbage, PhD, CCC-SLP
Course: #9472Level: Intermediate1 Hour
  'Knowledgeable presenter who provided a lot of evidenced based material'   Read Reviews
This course will address the theoretical underpinnings and research base related to differential diagnosis and treatment of articulation and phonological deficits in children with speech sound disorders. Special considerations for how to tailor evaluation and intervention to meet the needs of school-age children will be discussed.

The Ripple Effect of Stuttering: A Community-Based Approach
Presented by Craig Coleman, MA, CCC-SLP, BCS-F, ASHA Fellow, Mary Weidner, PhD, CCC-SLP
Video

Presenters

Craig Coleman, MA, CCC-SLP, BCS-F, ASHA FellowMary Weidner, PhD, CCC-SLP
Course: #9217Level: Intermediate2 Hours
  'Great content! Looking forward to using these strategies in my therapy sessions'   Read Reviews
This is Part 2 of a four-part series. The stuttering experience has a ripple effect that extends far beyond the child who stutters. Parents, teachers, peers, and others must possess both knowledge and skills to best support children who stutter. This course will highlight new clinical tools and resources to provide a community-based treatment approach for stuttering. (Part 1 - Course 9278, Part 3 - Course 9301, Part 4 - Course 9304)

Behavioral Frameworks for Dementia Management
Presented by Mary Beth Mason, PhD, CCC-SLP, Robert W. Serianni, MS, CCC-SLP, FNAP
Video

Presenters

Mary Beth Mason, PhD, CCC-SLPRobert W. Serianni, MS, CCC-SLP, FNAP
Course: #9473Level: Intermediate1 Hour
  'Material was presented well and very organized'   Read Reviews
This course will focus on cognitive-communication intervention strategies for various dementia presentations and will provide a review of evidence-based treatment. Behavioral frameworks along with their rationales will be introduced and applied across several dementia types and mild, moderate and severe levels of impairment.

20Q: Infection Control Strategies for SLPs
Presented by A.U. Bankaitis Smith, PhD
Text

Presenter

A.U. Bankaitis Smith, PhD
Course: #9729Level: Intermediate1 Hour
  'I prefer videos courses'   Read Reviews
Speech-language pathologists are expected by policy authorities to apply appropriate measures to protect patients, co-workers and themselves in clinical situations that may expose individuals to infectious microbes. This article provides practical guidelines for implementing infection control principles within the context of the COVID-19 pandemic, including discussion of personal protective equipment (PPE) and disinfecting and cleaning products.

Thickened Liquids in Clinical Practice: The Plot “Thickens”
Presented by Angela Mansolillo, MA, CCC-SLP, BCS-S
Video

Presenter

Angela Mansolillo, MA, CCC-SLP, BCS-S
Course: #10497Level: Intermediate1 Hour
  'Working in the healthcare system, thickening liquids are a concern we frequently encounter'   Read Reviews
Clinicians who utilize thickened liquids in their clinical practice are aware of their benefits, but what about the risks and contraindications? Advantages and disadvantages of thickened liquids are reviewed in this course with a focus on clinical outcomes, including impacts on medication administration, lung health, and hydration. Product types are evaluated to facilitate appropriate choices for individual clients.

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.